Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$192M |
| 2 |
Johnson & Johnson
JNJ
|
+$179M |
| 3 |
EMC
EMC CORPORATION
EMC
|
+$177M |
| 4 |
Chubb
CB
|
+$153M |
| 5 |
Eli Lilly
LLY
|
+$142M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$470M |
| 2 |
PRE
PARTNERRE LTD
PRE
|
+$186M |
| 3 |
Comcast
CMCSA
|
+$179M |
| 4 |
Pfizer
PFE
|
+$168M |
| 5 |
Gilead Sciences
GILD
|
+$144M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 11.92% |
| 2 | Healthcare | 11.63% |
| 3 | Technology | 11.35% |
| 4 | Industrials | 10.55% |
| 5 | Consumer Staples | 10.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Take-Two Interactive
TTWO
$46.8B
| $62.8M | 0.12% |
1,666,750
-222,700
| -12% | -$7.71M |
|
177
Zoetis
ZTS
$31.1B
| $62.6M | 0.12% |
1,413,100
+1,129,700
| +399% | +$47.9M |
|
178
Healthpeak Properties
DOC
$14.1B
| $62.4M | 0.12% |
2,104,537
+217,185
| +12% | +$6.52M |
|
179
Cogent Communications
CCOI
$554M
| $62.4M | 0.12% |
1,597,900
+84,400
| +6% | +$2.93M |
|
|
DCM
180
DELISTED
NTT DOCOMO, Inc.
DCM
| $61.8M | 0.12% |
2,712,000
+102,400
| +4% | +$2.29M |
|
|
AIV
181
Aimco
AIV
$376M
| $61.5M | 0.12% |
11,040,144
+2,032,092
| +23% | +$10.4M |
|
|
BXLT
182
DELISTED
BAXALTA INC COM STK (DE)
BXLT
| $61.4M | 0.12% |
+1,521,000
| New | +$60.2M |
|
183
Ingredion
INGR
$6.6B
| $61.1M | 0.12% |
572,064
+568,064
| +14,202% | +$56.6M |
|
184
Live Nation Entertainment
LYV
$42.7B
| $60.8M | 0.12% |
2,725,166
+792,000
| +41% | +$17.3M |
|
185
Prologis
PLD
$133B
| $60.5M | 0.12% |
1,368,871
+1,360,171
| +15,634% | +$54.6M |
|
186
Under Armour
UAA
$2.29B
| $60.5M | 0.11% |
1,425,200
+1,271,800
| +829% | +$50.2M |
|
187
SiriusXM
SIRI
$9.61B
| $60.1M | 0.11% |
1,521,700
-1,020,830
| -40% | -$38.1M |
|
188
Mondelez International
MDLZ
$78.9B
| $60.1M | 0.11% |
+1,498,098
| New | +$61M |
|
189
Delta Air Lines
DAL
$59.5B
| $60M | 0.11% |
1,232,600
+1,173,200
| +1,975% | +$54.8M |
|
190
Centene
CNC
$32.1B
| $60M | 0.11% |
1,947,660
-989,140
| -34% | -$29.5M |
|
191
Progressive
PGR
$123B
| $59.7M | 0.11% |
1,698,700
+1,417,300
| +504% | +$45.3M |
|
192
Molson Coors Class B
TAP
$7.83B
| $59.6M | 0.11% |
619,900
+88,900
| +17% | +$7.93M |
|
193
Equity Residential
EQR
$24.4B
| $59.6M | 0.11% |
793,800
+80,700
| +11% | +$6.04M |
|
|
NUAN
194
DELISTED
Nuance Communications, Inc.
NUAN
| $59.5M | 0.11% |
3,675,967
+75,075
| +2% | +$1.21M |
|
|
GG
195
DELISTED
Goldcorp Inc
GG
| $58.2M | 0.11% |
3,587,561
+1,371,300
| +62% | +$19.1M |
|
|
IDTI
196
DELISTED
Integrated Device Technology I
IDTI
| $58.2M | 0.11% |
2,845,753
+404,100
| +17% | +$8.49M |
|
|
NTRI
197
DELISTED
NutriSystem, Inc.
NTRI
| $58M | 0.11% |
2,777,800
+56,800
| +2% | +$1.12M |
|
198
Berkshire Hathaway Class A
BRK.A
$1.11T
| $57.4M | 0.11% |
269
+135
| +101% | +$26.9M |
|
199
Deere & Co
DE
$167B
| $57.4M | 0.11% |
745,300
-22,200
| -3% | -$1.74M |
|
|
PNY
200
DELISTED
PIEDMONT NATURAL GAS CO INC(NC
PNY
| $57.3M | 0.11% |
957,300
+617,400
| +182% | +$36.4M |
|
Similar funds
Jim Simons's Q1 2016 Portfolio in Review
As of Q1 2016, Jim Simons held 3,753 positions worth $52.6B, up 15% from $45.9B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.31B of net new capital in Q1 2016, opening 498 new positions and adding to 2,018 existing holdings. Its largest new stake was EMC CORPORATION: 7,000,400 shares worth $187M.
By sector, the portfolio is most concentrated in Financials at 12% of assets, up from 11% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Pfizer, an estimated $168M trimmed.
- Jim Simons's largest Q1 2016 buy was EMC CORPORATION: 7,000,400 shares worth $187M.
- Jim Simons added most to PepsiCo in Q1 2016, an estimated $192M increase.
- Jim Simons's biggest Q1 2016 reduction was Pfizer, cutting an estimated $168M.
- Jim Simons fully exited Apple in Q1 2016, selling an estimated $470M.
- Jim Simons's ten largest holdings make up 7.9% of its $52.6B portfolio in Q1 2016.
- Jim Simons opened 498 new positions and closed 403 in Q1 2016.
- Jim Simons's portfolio value rose 15% quarter-over-quarter to $52.6B.
Based on Renaissance Technologies's 13F filing for Q1 2016, filed 13 May 2016.